Germany: Troubled Waters for Pharma IP
Veröffentlichung | 01.09.2008
Author(s): Dr. Thorsten Bausch
Thorsten Bausch, European and German patent attorney, partner and member of HOFFMANN EITLE's chemistry group, has written an article on the apparent difficulty of pharma patents to survive revocation proceedings before the German Federal Patent Court. His contribution was recently published in Managing Intellectual Property's September 2008 edition, as part of the supplement "Europe IP Focus 2008 4th edition".
The full article can be viewed in MIP's online edition at:
https://www.managingip.com/germany-troubled-waters-for-pharma-ip